Overview

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

Status:
Completed
Trial end date:
2010-07-18
Target enrollment:
Participant gender:
Summary
This is a double-blind, single center, parallel group, placebo and active comparator, controlled study to characterize the wake promoting effects of single doses of SPD489 in healthy adult male undergoing acute sleep deprivation.
Phase:
Phase 2
Details
Lead Sponsor:
Shire
Treatments:
Armodafinil
Lisdexamfetamine Dimesylate
Modafinil